Skip to main content
Clinical Trials/NCT03079596
NCT03079596
Unknown
Not Applicable

Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study)

Seoul National University Bundang Hospital1 site in 1 country100 target enrollmentOctober 1, 2019
ConditionsGastric Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastric Cancer
Sponsor
Seoul National University Bundang Hospital
Enrollment
100
Locations
1
Primary Endpoint
Tolerance of diet for 24 hours
Last Updated
4 years ago

Overview

Brief Summary

Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of reducing the surgical stress response and obtaining optimal recovery after surgery.

Detailed Description

There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of conventional treatment. However, few studies exist about the implication of ERAS programs in the laparoscopic gastrectomy. The aim of this study was to compare the recovery rate, morbidity, and quality of life in the patients undergoing laparoscopic total gastrectomy and proximal gastrectomy for gastric cancer, receiving either ERAS protocol or conventional postoperative cares.

Registry
clinicaltrials.gov
Start Date
October 1, 2019
End Date
December 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sang-Hoon Ahn

Profesor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • Elective surgery
  • American Society of Anesthesiologists (ASA) scores \< 3
  • Gastric cancer, adenocarcinoma, possible to perform laparoscopic total gastrectomy and proximal gastrectomy
  • Informed consent
  • No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer or other type of cancer.
  • No systemic inflammatory disease

Exclusion Criteria

  • conversion to open

Outcomes

Primary Outcomes

Tolerance of diet for 24 hours

Time Frame: 4 days after surgery

Tolerance of diet for 24 hours. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting

Analgesic-free

Time Frame: 4 days after surgery

Analgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA)

Safe ambulation

Time Frame: 4 days after surgery

Safe ambulation (ambulation of 600m without assistance)

Afebrile status without major complications

Time Frame: 4 days after surgery

Afebrile status without major complications (fever defined as body temperature greater than 37.5)

Secondary Outcomes

  • Postoperative length of hospital stay(up to 4 weeks after surgery)
  • Time to tolerance of a full diet(up to 1 month after surgery)
  • Time to first bowel motion(up to 7 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials